{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:59:21Z","timestamp":1760608761388},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["SpringerPlus"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Chronic internal inflammation secondary to adiposity is a risk factor for sporadic breast cancer and Post-Menopausal Breast Cancer (PMBC) is largely defined as such. Adiposity is one of the clinical criteria for the diagnosis of Metabolic Syndrome (MetS) and is a risk factor for PMBC. We examined SNPs of eight genes implicated in adiposity, inflammation and cell proliferation in a Prospective-specimen-collection, Retrospective-Blinded-Evaluation (PRoBE) design approach. A total of 180 cases and 732 age-matched controls were identified from the MyCode prospective biobank database and then linked to the Clinical Decision Information System, an enterprise-wide data warehouse, to retrieve clinico-demographic data. Samples were analyzed in a core laboratory where the personnel were masked to their status. Results from multivariate logistic regression yielded one SNP (rs2922126) in the GHSR as protective against PMBC among homozygotes for the minor allele (A\/A) (OR\u2009=\u20090.4, 95% CI 0.18-.89, P-value\u2009=\u2009.02); homozygosity for the minor allele (C\/C) of the SNP (rs889312) of the gene MAP3K1 was associated with the risk of PMBC (OR\u2009=\u20092.41, 95% CI 1.25-4.63 P-value\u2009=\u2009.008). Advanced age was protective against PMBC (OR\u2009=\u20090.98, 95% CI 0.95-0.99, P-value\u2009=\u2009.02). Family history of breast cancer (OR\u2009=\u20092.22, 95% CI 1.14-4.43. P\u2009=\u2009.02), HRT (OR\u2009=\u20093.35; 95% CI 2.15-5.21, P\u2009&lt;\u2009.001), and MetS (OR\u2009=\u200914.83, 95% CI 5.63-39.08, P\u2009&lt;\u2009.001) and interaction between HRT and MetS (OR\u2009=\u200939.38, 95% CI 15.71-98.70, P\u2009&lt;\u2009.001) were associated with the risk of PMBC. We did not detected significant interactions between SNPs or between the SNPs and the clinico-demographic risk factors. Our study further confirms that MetS increases the risk of PMBC and argues in favor of reducing exposure to HRT. Our findings are another confirmation that low penetrance genes involved in the inflammatory pathway, i.e. MAP3KI gene, may have a plausible causative role in PMBC. Given the fact that genetic constitutionality of individuals cannot be changed, efforts should be focused on life style modification.<\/jats:p>","DOI":"10.1186\/2193-1801-2-638","type":"journal-article","created":{"date-parts":[[2013,11,27]],"date-time":"2013-11-27T14:03:10Z","timestamp":1385560990000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adiposity, inflammation, genetic variants and risk of post-menopausal breast cancer findings from a prospective-specimen-collection, retrospective-blinded-evaluation (PRoBE) design approach"],"prefix":"10.1186","volume":"2","author":[{"given":"Xiaowei Sherry","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Barnholtz-Sloan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Colonie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Smelser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikitaban","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery","family":"Prichard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azadeh","family":"Stark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,27]]},"reference":[{"issue":"Suppl 1","key":"687_CR1","doi-asserted-by":"publisher","first-page":"s74","DOI":"10.3109\/07853890.2012.663928","volume":"44","author":"R Aghamohammadzaeh","year":"2012","unstructured":"Aghamohammadzaeh R, Heagerty A: Obesity-related hypertension: epidemiology, pathophysiology, treatment, and the contribution of Perivascular adipose tissue. Ann Med 2012, 44(Suppl 1):s74-s84.","journal-title":"Ann Med"},{"key":"687_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.numecd.2009.02.006","volume":"20","author":"C Agnoli","year":"2010","unstructured":"Agnoli C, Berrino F, Abagnato CA, et al.: Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case\u2013control study. Nutr Metab Cardiovasc Dis 2010, 20: 41-48. 10.1016\/j.numecd.2009.02.006","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"687_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2337\/db07-0910","volume":"57","author":"CH Andreasen","year":"2008","unstructured":"Andreasen CH, Stender-Peteren KL, Mogensen MS, et al.: Low Physical activity accentuate the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes 2008, 57: 95-101.","journal-title":"Diabetes"},{"key":"687_CR4","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1158\/1055-9965.EPI-10-0230","volume":"19","author":"T Bjorge","year":"2010","unstructured":"Bjorge T, Lukanova A, Jonsson H, et al.: Metabolic syndrome and breast cancer in the Me-Can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomark Prev 2010, 19: 1737-1745. 10.1158\/1055-9965.EPI-10-0230","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"687_CR5","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s13105-012-0154-2","volume":"68","author":"I Bondia-Pons","year":"2012","unstructured":"Bondia-Pons I, Ryan L, Martinez JA: Oxidative stress and inflammation interactions in human obesity. J Physiol Biochem 2012, 68: 701-711. 10.1007\/s13105-012-0154-2","journal-title":"J Physiol Biochem"},{"key":"687_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10549-010-1082-x","volume":"126","author":"TM Brasky","year":"2011","unstructured":"Brasky TM, Bonner MR, Moysich KB, et al.: Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York exposures and breast cancer (WEB) study. Breast Cancer Res Treat 2011, 126: 157-165. 10.1007\/s10549-010-1082-x","journal-title":"Breast Cancer Res Treat"},{"key":"687_CR7","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.7150\/ijbs.7.1003","volume":"7","author":"S Braun","year":"2011","unstructured":"Braun S, Bitton-Worms K, LeRoith D: The link between metabolic syndrome and cancer. Int J Biol Sci 2011, 7: 1003-1015.","journal-title":"Int J Biol Sci"},{"key":"687_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1467-789X.2006.00261.x","volume":"7","author":"AR Carmichael","year":"2006","unstructured":"Carmichael AR: Diagnostic in obesity comorbidities, obesity and prognosis of breast cancer. Obes Rev 2006, 7: 333-340. 10.1111\/j.1467-789X.2006.00261.x","journal-title":"Obes Rev"},{"key":"687_CR9","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1093\/hmg\/11.20.2463","volume":"11","author":"HJ Cordell","year":"2002","unstructured":"Cordell HJ: Epistasis: what it means, what it doesn\u2019t mean, and statistical methods to detect it in humans. Human Mol Gent 2002, 11: 2463-2468. 10.1093\/hmg\/11.20.2463","journal-title":"Human Mol Gent"},{"key":"687_CR10","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.2353\/ajpath.2006.051090","volume":"169","author":"S Cowey","year":"2006","unstructured":"Cowey S, Hardy RW: The metabolic syndrome; a high-risk for cancer? Am J Pathol 2006, 169: 1505-1522. 10.2353\/ajpath.2006.051090","journal-title":"Am J Pathol"},{"key":"687_CR11","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/jnci\/djp018","volume":"101","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, Tice JA, Bauer S, et al.: Prevention of breast cancer in post-menopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst 2009, 101: 384-398. 10.1093\/jnci\/djp018","journal-title":"J Natl Cancer Inst"},{"key":"687_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1172\/JCI200421134","volume":"114","author":"VD Dixit","year":"2004","unstructured":"Dixit VD, Schaffer EM, Pyle RS, et al.: Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 2004, 114: 57-65.","journal-title":"J Clin Invest"},{"key":"687_CR13","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1093\/carcin\/bgn083","volume":"29","author":"L Dossus","year":"2008","unstructured":"Dossus L, McKay JD, Canzian F, et al.: Polymorphism of genes for Ghrelin and its receptor in relation to anthropometry, circulating levels of IGF-I and IGFBP-3, and breast cancer risk: a case\u2013control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC). Carcinogenesis 2008, 29: 1360-1366. 10.1093\/carcin\/bgn083","journal-title":"Carcinogenesis"},{"key":"687_CR14","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/carcin\/bgp307","volume":"31","author":"L Dossus","year":"2010","unstructured":"Dossus L, Kaaks R, Canzian F, et al.: PTGS2 And IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3). Carcinogenesis 2010, 31: 455-461. 10.1093\/carcin\/bgp307","journal-title":"Carcinogenesis"},{"key":"687_CR15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJM198501173120303","volume":"312","author":"WD Dupont","year":"1985","unstructured":"Dupont WD, Page DL: Risk factors for breast cancer in women with proliferative breast disease. NEJM 1985, 312: 146-151. 10.1056\/NEJM198501173120303","journal-title":"NEJM"},{"key":"687_CR16","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/nature05887","volume":"447","author":"DF Easton","year":"2007","unstructured":"Easton DF, Pooley KA, Dunning AM, et al.: Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007, 447: 1087-1093. 10.1038\/nature05887","journal-title":"Nature"},{"key":"687_CR17","volume-title":"Menopause","author":"K Esposito","year":"2013","unstructured":"Esposito K, Chiodini P, Capuarno A, et al.: Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis. Menopause 2013. [Epub ahead of print]"},{"key":"687_CR18","volume-title":"Sensible use of ICD-9 diagnostic codes of observational data in breast and endometrial cancer research","author":"W Feng","year":"2013","unstructured":"Feng W, Yan X, Colonie R, et al.: Sensible use of ICD-9 diagnostic codes of observational data in breast and endometrial cancer research. San Francisco, CA: Abstract, Presented at the Annual of Meeting of the Health Maintenance Research Network; 2013."},{"key":"687_CR19","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/sj.ijo.0801792","volume":"25","author":"A Festa","year":"2001","unstructured":"Festa A, D\u2019Agostino R, Williams K, et al.: The relations of body fat mass and distribution to markers of chronic inflammation. Int J Obes 2001, 25: 1407-1415. 10.1038\/sj.ijo.0801792","journal-title":"Int J Obes"},{"key":"687_CR20","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1001\/jama.287.3.356","volume":"287","author":"ES Ford","year":"2002","unstructured":"Ford ES, Gile WH, Dietz WH: Prevalence of the metabolic syndrome among US adults, findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287: 356-359. 10.1001\/jama.287.3.356","journal-title":"JAMA"},{"key":"687_CR21","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1126\/science.1141634","volume":"316","author":"TM Frayling","year":"2007","unstructured":"Frayling TM, Timpson NJ, Weedon MN, et al.: A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316: 889-894. 10.1126\/science.1141634","journal-title":"Science"},{"key":"687_CR22","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1126\/science.1069424","volume":"296","author":"SB Gabriel","year":"2002","unstructured":"Gabriel SB, Schaffner SF, Nguyen H, et al.: The structure of haplotype blocks in the human genome. Science 2002, 296: 2225-2229. 10.1126\/science.1069424","journal-title":"Science"},{"key":"687_CR23","doi-asserted-by":"publisher","first-page":"e23302","DOI":"10.1371\/journal.pone.0023302","volume":"6","author":"MD Gahete","year":"2011","unstructured":"Gahete MD, Cordoba-Chaon J, Hergueta-Redondo M, et al.: A novel human Gherlin variant (In1-Gherlin) and Ghrelin-O-Acyltransferase are overexpressed in breast cancer: potential pathophysiological relevance. PLoS One 2011, 6: e23302. 10.1371\/journal.pone.0023302","journal-title":"PLoS One"},{"key":"687_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.mce.2009.08.018","volume":"25","author":"S Galic","year":"2010","unstructured":"Galic S, Oakhill JS, Steinberg GR: Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010, 25: 129-139.","journal-title":"Mol Cell Endocrinol"},{"key":"687_CR25","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1056\/NEJMra000471","volume":"346","author":"CJ Gruber","year":"2002","unstructured":"Gruber CJ, Tshcugguel W, Schneeberger C, et al.: Production and actions of estrogens. NEJM 2002, 346: 340-352. 10.1056\/NEJMra000471","journal-title":"NEJM"},{"key":"687_CR26","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1161\/01.ATV.0000189155.75833.c7","volume":"25","author":"SM Grundy","year":"2005","unstructured":"Grundy SM: Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung and Blood Institute. Arterioscler Thromb Vasc Biol 2005, 25: 2243-2244. 10.1161\/01.ATV.0000189155.75833.c7","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"687_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","volume":"109","author":"SM Grundy","year":"2004","unstructured":"Grundy SM, Brewer HB, Cleeman JI, et al.: Definition of metabolic syndrome. Report of the National Heart, Lung and Blood Institute\/American Heart Association conference on scientific issue related to definition. Circulation 2004, 109: 433-438. 10.1161\/01.CIR.0000111245.75752.C6","journal-title":"Circulation"},{"key":"687_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/jnci\/djn415","volume":"101","author":"MJ Gunter","year":"2009","unstructured":"Gunter MJ, Hoover DR, Yu H, et al.: Insulin, Insulin-like growth factor-I and risk f breast cancer in postmenopausal women. J Natl Cancer Inst 2009, 101: 48-60. 10.1093\/jnci\/djn415","journal-title":"J Natl Cancer Inst"},{"key":"687_CR29","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00432-012-1176-4","volume":"138","author":"EA Hamed","year":"2012","unstructured":"Hamed EA, Zakhary MM, Maximous DW: Apoptosis, angiogenesis, inflammation and oxidative stress: basic interactions in patients with early and metastatic breast cancer. J Cancer Res Clin Oncol 2012, 138: 999-1009. 10.1007\/s00432-012-1176-4","journal-title":"J Cancer Res Clin Oncol"},{"key":"687_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa044383","volume":"353","author":"LC Hartman","year":"2005","unstructured":"Hartman LC, Sellers TH, Frost MH, et al.: Benign breast disease and the risk of breast cancer. NEJM 2005, 353: 229-237. 10.1056\/NEJMoa044383","journal-title":"NEJM"},{"key":"687_CR31","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1093\/carcin\/bgr214","volume":"32","author":"CS Healey","year":"2011","unstructured":"Healey CS, Ahmed S, ANECS, et al.: Breast cancer susceptibility polymorphisms and endometrial cancer risk: a collaborative endometrial cancer study. Carcinogenesis 2011, 32: 1862-1866. 10.1093\/carcin\/bgr214","journal-title":"Carcinogenesis"},{"key":"687_CR32","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/ng2075","volume":"39","author":"DJ Hunter","year":"2007","unstructured":"Hunter DJ, Kraft P, Jacobs KB, et al.: A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Gen 2007, 39: 870-874. 10.1038\/ng2075","journal-title":"Nat Gen"},{"key":"687_CR33","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1002\/ijc.23173","volume":"121","author":"SP Hussain","year":"2007","unstructured":"Hussain SP, Harris CC: Inflammation and cancer: an ancient link with novel potential. Int J Cancer 2007, 121: 2373-2380. 10.1002\/ijc.23173","journal-title":"Int J Cancer"},{"key":"687_CR34","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1158\/1055-9965.EPI-05-0185","volume":"14","author":"ML Irvin","year":"2005","unstructured":"Irvin ML, McTiernan A, Bernstein L, et al.: Relationship of obesity and physical activity with C-peptide, Leptin and Insulin-like growth factor in breast cancer survivors. Cancer Epidemiol Biomarers Prev 2005, 14: 2881-2888. 10.1158\/1055-9965.EPI-05-0185","journal-title":"Cancer Epidemiol Biomarers Prev"},{"key":"687_CR35","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1158\/1055-9965.EPI-09-0235","volume":"18","author":"GC Kabat","year":"2009","unstructured":"Kabat GC, Kim M, Chlebowski RT, et al.: A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer. Cancer Epidem Biomarkers Prev 2009, 18: 2046-2053. 10.1158\/1055-9965.EPI-09-0235","journal-title":"Cancer Epidem Biomarkers Prev"},{"key":"687_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2350-12-52","volume":"12","author":"V Kakamani","year":"2011","unstructured":"Kakamani V, Yi N, Sadim M, et al.: The role of the fat mass and obesity associated gene (FTO) in breast cancer risk. BMC Med Gen 2011, 12: 52-59.","journal-title":"BMC Med Gen"},{"key":"687_CR37","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1152\/physrev.00028.2011","volume":"92","author":"JM Kyriakis","year":"2012","unstructured":"Kyriakis JM, Avruch J: Mammalina MAPK signal transduction pathways activated by stress and inflammation: A 10-year old udate. Physiol Rev 2012, 92: 689-737. 10.1152\/physrev.00028.2011","journal-title":"Physiol Rev"},{"key":"687_CR38","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1158\/1078-0432.CCR-05-2055","volume":"12","author":"U Langsenlehner","year":"2006","unstructured":"Langsenlehner U, Yasdani-Biuki B, Eder T, et al.: The cyclooxygenase-2 (PTGS2) 8473\u00a0T\u2009>\u2009C polymorphism is associated with breast cancer risk. Clin Cancer Res 2006, 12: 1392-1394. 10.1158\/1078-0432.CCR-05-2055","journal-title":"Clin Cancer Res"},{"key":"687_CR39","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/bmj.321.7261.624","volume":"321","author":"K McPherson","year":"2000","unstructured":"McPherson K, Steel CM, Dixon JM: Breast cancer- epidemiology, risk factors and genetics. BMJ 2000, 321: 624-628. 10.1136\/bmj.321.7261.624","journal-title":"BMJ"},{"key":"687_CR40","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/jnci\/djh336","volume":"96","author":"SA Missmer","year":"2004","unstructured":"Missmer SA, Eliassen H, Barbieri RL, et al.: Endogenous estrogen, androgen, and progesterone concentration and breast cancer risk among postmenopausal women. J Natl Cancer Inst 2004, 96: 1856-1865. 10.1093\/jnci\/djh336","journal-title":"J Natl Cancer Inst"},{"key":"687_CR41","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1158\/1940-6207.CAPR-11-0110","volume":"4","author":"PG Morris","year":"2011","unstructured":"Morris PG, Hudis CA, Giri D, et al.: Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res 2011, 4: 1021-1029. 10.1158\/1940-6207.CAPR-11-0110","journal-title":"Cancer Prev Res"},{"key":"687_CR42","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1158\/1541-7786.MCR-07-2126","volume":"6","author":"T Ozhay","year":"2008","unstructured":"Ozhay T, Nahta R: A novel unidirectional cross-talk from the insulin-like growth factor-I receptor to leptin receptor in human breast cancer cells. Mol Cancer Res 2008, 6: 1052-1056. 10.1158\/1541-7786.MCR-07-2126","journal-title":"Mol Cancer Res"},{"key":"687_CR43","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1093\/jnci\/djn326","volume":"100","author":"MS Pepe","year":"2008","unstructured":"Pepe MS, Feng Z, Janes H, et al.: Pivotal evaluation of the accuracy of a biomarker used for classification for prediction: standards for study design. J Natl Cancer Inst 2008, 100: 1432-1438. 10.1093\/jnci\/djn326","journal-title":"J Natl Cancer Inst"},{"key":"687_CR44","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1017\/S0029665112000092","volume":"71","author":"F Perez De Heredia","year":"2012","unstructured":"Perez De Heredia F, Gomez-Martiez S, Marcos A: Chronic and degenerative diseases, obesity, inflammation and the immune system. Proc Nutr Soc 2012, 71: 332-338. 10.1017\/S0029665112000092","journal-title":"Proc Nutr Soc"},{"key":"687_CR45","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1189\/jlb.1107762","volume":"84","author":"JW Pollard","year":"2008","unstructured":"Pollard JW: Macrophages define the invasive microenvironment in breast cancer. J Leukoc Biol 2008, 84: 623-630. 10.1189\/jlb.1107762","journal-title":"J Leukoc Biol"},{"key":"687_CR46","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1172\/JCI33295","volume":"117","author":"K Polyak","year":"2007","unstructured":"Polyak K: Breast cancer: origins and evolution. J Clin Invest 2007, 117: 3155-3163. 10.1172\/JCI33295","journal-title":"J Clin Invest"},{"key":"687_CR47","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/carcin\/bgn247","volume":"30","author":"TR Rebbeck","year":"2009","unstructured":"Rebbeck TR, DeMichele A, Tran TV, et al.: Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women. Carcinogenesis 2009, 30: 269-274.","journal-title":"Carcinogenesis"},{"key":"687_CR48","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1093\/annonc\/mdr025","volume":"22","author":"V Rosato","year":"2011","unstructured":"Rosato V, Bosetti C, Talamini R, et al.: Metabolic syndrome and the risk of breast cancer in postmenopausal women. Ann Oncol 2011, 22: 2687-2692. 10.1093\/annonc\/mdr025","journal-title":"Ann Oncol"},{"key":"687_CR49","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/sj.bjc.6605025","volume":"100","author":"L Rosenberg","year":"2009","unstructured":"Rosenberg L, Czene K, Hall P: Obesity and poor breast cancer prognosis: an illusion because of hormone replacement therapy? Br J Cancer 2009, 100: 1486-1491. 10.1038\/sj.bjc.6605025","journal-title":"Br J Cancer"},{"key":"687_CR50","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","volume":"92","author":"RK Ross","year":"2000","unstructured":"Ross RK, Paganini-Hill A, Wan PC, et al.: Effect of hormone replacement therapy on breast cancer risk: Estrogen vs. Estrogen plus progestin. J Natl Cancer Inst 2000, 92: 328-332. 10.1093\/jnci\/92.4.328","journal-title":"J Natl Cancer Inst"},{"key":"687_CR51","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1001\/jama.283.4.485","volume":"283","author":"C Schairer","year":"2000","unstructured":"Schairer C, Lubin J, Troisi R, et al.: Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 2000, 283: 485-491. 10.1001\/jama.283.4.485","journal-title":"JAMA"},{"key":"687_CR52","first-page":"55","volume":"6","author":"D Sinagra","year":"2002","unstructured":"Sinagra D, Scarpitta AM, Brigandi M, et al.: Metabolic syndrome and breast cancer risk. Eur Rev Med Pharmcol Sci 2002, 6: 55-59.","journal-title":"Eur Rev Med Pharmcol Sci"},{"key":"687_CR53","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/aje\/kwn143","volume":"168","author":"BL Sprague","year":"2008","unstructured":"Sprague BL, Trentham-Dietz A, Egan KM, et al.: Proportion of invasive breast cancer attributable to risk factors modifiable after menopause. Am J Epidemiol 2008, 168: 404-411. 10.1093\/aje\/kwn143","journal-title":"Am J Epidemiol"},{"key":"687_CR54","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/ng2064","volume":"39","author":"SN Stacey","year":"2007","unstructured":"Stacey SN, Manolescu A, Sulem P, et al.: Common variants on chromosome 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Gen 2007, 39: 865-869. 10.1038\/ng2064","journal-title":"Nat Gen"},{"key":"687_CR55","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1158\/1055-9965.EPI-08-0212","volume":"17","author":"LJ Vatten","year":"2008","unstructured":"Vatten LJ, Holly JM, Gunnell D, et al.: Nested case\u2013control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway. Cancer Epidemiol Biomark Prev 2008, 17: 2097-2100. 10.1158\/1055-9965.EPI-08-0212","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"687_CR56","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1042\/bj3130017","volume":"313","author":"H Wiseman","year":"1996","unstructured":"Wiseman H, Halliwell B: Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 1996, 313: 17-29.","journal-title":"Biochem J"},{"key":"687_CR57","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.canlet.2011.12.033","volume":"319","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Zhou D, Lai Y, et al.: Estrogen induces endometrial cancer cell proliferation and invasion by regulating the fat mass and obesity associate gene via PI3K\/AKT and MAPK signaling pathways. Cancer Lett 2012, 319: 89-97. 10.1016\/j.canlet.2011.12.033","journal-title":"Cancer Lett"}],"container-title":["SpringerPlus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/2193-1801-2-638.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:23:56Z","timestamp":1630549436000},"score":1,"resource":{"primary":{"URL":"https:\/\/springerplus.springeropen.com\/articles\/10.1186\/2193-1801-2-638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,27]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["687"],"URL":"https:\/\/doi.org\/10.1186\/2193-1801-2-638","relation":{},"ISSN":["2193-1801"],"issn-type":[{"value":"2193-1801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,27]]},"assertion":[{"value":"11 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"638"}}